Effect of Pecha Kucha-Based Education on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
The Effect of Education Provided Using the PechaKucha Method on Symptom Management and Quality of Life in Patients Receiving Chemotherapy
This randomized controlled study aims to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. Participants will be randomly assigned to either an intervention group or a control group.
Participants in the intervention group will receive individual education on symptom management during chemotherapy using the PechaKucha method. The education will be delivered as a video presentation consisting of 20 visual slides and lasting 6 minutes and 40 seconds. Participants in the control group will receive routine/standard patient education.
Symptom severity and quality of life will be assessed before the education and one week after the intervention using the Edmonton Symptom Assessment System (ESAS) and the EQ-5D. The study will compare changes in symptom severity and quality of life between the intervention and control groups to determine whether PechaKucha-based education is effective in supporting symptom management and quality of life among patients receiving chemotherapy.
Tutkimuksen yleiskatsaus
Tila
Yksityiskohtainen kuvaus
This randomized controlled experimental study is designed to evaluate the effect of education delivered using the PechaKucha method on symptom management and quality of life in patients receiving chemotherapy. The study is being conducted in the Chemotherapy Unit of Health Sciences University Kanuni Sultan Süleyman Training and Research Hospital, with participant enrollment beginning in June 2026.
Participants will be assigned to an intervention group or a control group. Participants in the intervention group will receive individual education on "Symptom Management During Chemotherapy," delivered by the researchers using the PechaKucha method. The educational intervention will be presented as a video consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds. The educational content addresses common chemotherapy-related symptoms and problems, including pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia. Participants in the control group will receive routine/standard patient education.
Data will be collected through face-to-face interviews. At baseline, participants in both groups will complete the Patient Information Form, the Edmonton Symptom Assessment System (ESAS), and the EQ-5D. One week after the intervention, the ESAS and EQ-5D will be administered again to participants in both groups. The Patient Information Form, which is used to obtain demographic and clinical information, will be administered only at baseline.
Between-group comparisons will be performed using the independent-samples t-test or Mann-Whitney U test, as appropriate. Within-group pretest-posttest comparisons will be performed using the paired-samples t-test or Wilcoxon signed-rank test, as appropriate. Statistical significance will be set at p < 0.05.
Before participation, individuals will receive written and verbal information about the study, and informed consent will be obtained from all participants.
Opintotyyppi
Ilmoittautuminen (Arvioitu)
Vaihe
- Ei sovellettavissa
Yhteystiedot ja paikat
Opiskeluyhteys
- Nimi: Asiye TAN, Ph D
- Puhelinnumero: 05055675275
- Sähköposti: asiyetan@aydin.edu.tr
Tutki yhteystietojen varmuuskopiointi
- Nimi: Dilek YILDIRIM, Ph D
- Puhelinnumero: +905331421987
- Sähköposti: dilekyildirim@aydin.edu.tr
Opiskelupaikat
-
-
-
Istanbul, Turkki (Türkiye), 34520
- Rekrytointi
- SBÜ Kanuni Sultan Süleyman E.A.H
-
Ottaa yhteyttä:
- Asiye TAN, Ph D
- Puhelinnumero: +90 05055675275
- Sähköposti: asiyetan@aydin.edu.tr
-
Ottaa yhteyttä:
- Dilek Yıldırım, Ph D
- Puhelinnumero: +90 05331421987
- Sähköposti: dilekyildirim@aydin.edu.tr
-
Alatutkija:
- Zülfiye Tosun Öztürkçi, MSc
-
-
Osallistumiskriteerit
Kelpoisuusvaatimukset
Opintokelpoiset iät
- Aikuinen
- Vanhempi Aikuinen
Hyväksyy terveitä vapaaehtoisia
Kuvaus
Inclusion Criteria:
- Willing to participate in the study.
- Currently receiving treatment in the chemotherapy unit.
- Aged 18 years or older, willing to participate, and able to communicate effectively.
Exclusion Criteria:
- Being under 18 years of age.
- Having cognitive or communication difficulties.
- Having a visual or hearing impairment.
- Being in an advanced or terminal stage of the disease.
- Having a physical or psychological condition that prevents active participation in the educational process.
Opintosuunnitelma
Miten tutkimus on suunniteltu?
Suunnittelun yksityiskohdat
- Ensisijainen käyttötarkoitus: Tukevaa hoitoa
- Jako: Satunnaistettu
- Inventiomalli: Rinnakkaistehtävä
- Naamiointi: Ei mitään (avoin tarra)
Aseet ja interventiot
Osallistujaryhmä / Arm |
Interventio / Hoito |
|---|---|
|
Kokeellinen: PechaKucha-Based Education Group
Participants in this arm will receive individual education on "Symptom Management During Chemotherapy" delivered by the researchers using the PechaKucha method.
The education will be provided as a video presentation consisting of 20 visual slides with a total duration of 6 minutes and 40 seconds.
The educational content covers pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
|
The intervention consists of individual education on symptom management during chemotherapy delivered by the researchers using the PechaKucha method.
The education is provided as a video presentation consisting of 20 visual slides, with each slide displayed for 20 seconds, for a total duration of 6 minutes and 40 seconds.
The educational content addresses pain, nausea, anemia, fatigue, diarrhea, constipation, risk of infection, anxiety, depression, mucositis, and alopecia.
|
|
Active Comparator: Routine/Standard Education Group
Participants in this arm will receive routine/standard patient education provided as part of usual care in the chemotherapy unit.
No PechaKucha-based education will be provided to participants in this group.
|
Participants assigned to the control group will receive routine/standard patient education provided as part of usual care in the chemotherapy unit.
This education does not include the PechaKucha-based symptom management education provided to the intervention group.
|
Mitä tutkimuksessa mitataan?
Ensisijaiset tulostoimenpiteet
Tulosmittaus |
Toimenpiteen kuvaus |
Aikaikkuna |
|---|---|---|
|
Change in Symptom Severity Assessed by the Edmonton Symptom Assessment System (ESAS)
Aikaikkuna: Baseline (before the intervention) and one week after the intervention
|
The Edmonton Symptom Assessment System (ESAS) will be used to assess symptom severity in patients receiving chemotherapy.
Participants rate the severity of each symptom on a numerical scale, with higher scores indicating greater symptom severity.
The intervention group will receive symptom management education using the PechaKucha presentation format, whereas the control group will receive the same educational content using a conventional teaching method.
Both groups will also receive a brochure summarizing the educational content.
ESAS will be administered to both groups at baseline and one week after the intervention.
Changes in symptom severity from baseline will be compared between the groups.
|
Baseline (before the intervention) and one week after the intervention
|
Yhteistyökumppanit ja tutkijat
Sponsori
Opintojen ennätyspäivät
Opi tärkeimmät päivämäärät
Opiskelun aloitus (Todellinen)
Ensisijainen valmistuminen (Arvioitu)
Opintojen valmistuminen (Arvioitu)
Opintoihin ilmoittautumispäivät
Ensimmäinen lähetetty
Ensimmäinen toimitettu, joka täytti QC-kriteerit
Ensimmäinen Lähetetty (Todellinen)
Tutkimustietojen päivitykset
Viimeisin päivitys julkaistu (Todellinen)
Viimeisin lähetetty päivitys, joka täytti QC-kriteerit
Viimeksi vahvistettu
Lisää tietoa
Tähän tutkimukseen liittyvät termit
Avainsanat
Muita asiaankuuluvia MeSH-ehtoja
Muut tutkimustunnusnumerot
- 240/2025
Yksittäisten osallistujien tietojen suunnitelma (IPD)
Aiotko jakaa yksittäisten osallistujien tietoja (IPD)?
IPD-suunnitelman kuvaus
Lääke- ja laitetiedot, tutkimusasiakirjat
Tutkii yhdysvaltalaista FDA sääntelemää lääkevalmistetta
Tutkii yhdysvaltalaista FDA sääntelemää laitetuotetta
Nämä tiedot haettiin suoraan verkkosivustolta clinicaltrials.gov ilman muutoksia. Jos sinulla on pyyntöjä muuttaa, poistaa tai päivittää tutkimustietojasi, ota yhteyttä register@clinicaltrials.gov. Heti kun muutos on otettu käyttöön osoitteessa clinicaltrials.gov, se päivitetään automaattisesti myös verkkosivustollemme .